Dubourg, Julie
3 papers on CoChatORCID 0000-0002-5514-8075
Most cited papers
- Verified
Challenges and opportunities in NASH drug development
Harrison, S. A., Allen, A. M., Dubourg, J., Noureddin, M., & Alkhouri, N. (2023) · Nature Medicine
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 353
- Verified
Evaluation of PXL065–deuterium-stabilized (R)-pioglitazone in patients with NASH: a phase II randomized placebo-controlled trial (DESTINY-1)
Harrison, S. A., Thang, C., Bolze, S., Dewitt, S., Hallakou-Bozec, S., Dubourg, J., Bedossa, P., Cusi, K., Ratziu, V., Grouin, J.-M., et al. (2023) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and Protection
Cited by 96
- Verified
Copeptin is increased in resistant hypertension
Mendes, M., Dubourg, J., Blanchard, A., Bergerot, D., Courand, P.-Y., Forni, V., Frank, M., Bobrie, G., Menard, J., & Azizi, M. (2016) · Journal of Hypertension
Blood Pressure and Hypertension StudiesRenin-Angiotensin System Studies
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free